rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2006-1-5
|
pubmed:abstractText |
Residual disease after initial surgery for ovarian cancer is the strongest prognostic factor for survival. However, the extent of surgical resection required to achieve optimal cytoreduction is controversial. Our goal was to estimate the effect of aggressive surgical resection on ovarian cancer patient survival.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0029-7844
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
107
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
77-85
|
pubmed:dateRevised |
2009-10-26
|
pubmed:meshHeading |
pubmed-meshheading:16394043-Adult,
pubmed-meshheading:16394043-Age Factors,
pubmed-meshheading:16394043-Aged,
pubmed-meshheading:16394043-Aged, 80 and over,
pubmed-meshheading:16394043-Analysis of Variance,
pubmed-meshheading:16394043-Confidence Intervals,
pubmed-meshheading:16394043-Disease-Free Survival,
pubmed-meshheading:16394043-Female,
pubmed-meshheading:16394043-Humans,
pubmed-meshheading:16394043-Middle Aged,
pubmed-meshheading:16394043-Multivariate Analysis,
pubmed-meshheading:16394043-Neoplasm, Residual,
pubmed-meshheading:16394043-Neoplasm Invasiveness,
pubmed-meshheading:16394043-Neoplasm Staging,
pubmed-meshheading:16394043-Ovarian Neoplasms,
pubmed-meshheading:16394043-Ovariectomy,
pubmed-meshheading:16394043-Predictive Value of Tests,
pubmed-meshheading:16394043-Probability,
pubmed-meshheading:16394043-Prognosis,
pubmed-meshheading:16394043-Risk Assessment,
pubmed-meshheading:16394043-Survival Analysis,
pubmed-meshheading:16394043-Treatment Outcome
|
pubmed:year |
2006
|
pubmed:articleTitle |
Aggressive surgical effort and improved survival in advanced-stage ovarian cancer.
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota 55905, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|